Metraipolis › archive › dc_a3d70a2efbe6
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial — Europe PMC PMID:41289027
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41289027
- DOI
- 10.1172/jci.insight.191266
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T06:32:52.363Z
- SHA-256 of the archived text
c1e682065997ecf1572fe4b5e20f4a411634464980ccae04fd25f3ad181e37e4- Stable URL of this page
https://metraipolis.com/documento/dc_a3d70a2efbe6
How to cite
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial — Europe PMC PMID:41289027 — Europe PMC (en), https://europepmc.org/article/MED/41289027 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a3d70a2efbe6 (Metraipolis archive dc_a3d70a2efbe6, sha256 c1e682065997ecf1572fe4b5e20f4a411634464980ccae04fd25f3ad181e37e4)
BibTeX
@misc{dca3d70a2efbe6,
title = {Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial — Europe PMC PMID:41289027},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41289027},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a3d70a2efbe6; sha256 c1e682065997ecf1572fe4b5e20f4a411634464980ccae04fd25f3ad181e37e4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41289027. Agents can read the archived copy with the MCP tool read_document.